EYPT

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Eyepoint Pharmaceuticals Inc

NASDAQ | EYPT

10.66

USD

(

0.00%

)

At Close (As of Jan 1, 1970)

$1.00B

Market Cap

-

P/E Ratio

-2.69

EPS

$14.91

52 Week High

$3.91

52 Week Low

HEALTHCARE

Sector

EYPT Chart

Recent Chart
Price Action

EYPT Technicals

Tags:

EYPT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $40M
Total Revenue $43M
Cost Of Revenue $3.7M
Costof Goods And Services Sold $3.7M
Operating Income -$146M
Selling General And Administrative $52M
Research And Development $133M
Operating Expenses $185M
Investment Income Net -
Net Interest Income $15M
Interest Income $15M
Interest Expense $14K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.5M
Income Before Tax -$131M
Income Tax Expense $90K
Interest And Debt Expense -
Net Income From Continuing Operations -$131M
Comprehensive Income Net Of Tax -
Ebit -$131M
Ebitda -$129M
Net Income -$131M

Revenue & Profitability

Earnings Performance

EYPT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $418M
Total Current Assets $383M
Cash And Cash Equivalents At Carrying Value $100M
Cash And Short Term Investments $100M
Inventory $2.3M
Current Net Receivables $607K
Total Non Current Assets $35M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $271M
Other Current Assets $9.5M
Other Non Current Assets -
Total Liabilities $82M
Total Current Liabilities $49M
Current Accounts Payable $12M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $33M
Capital Lease Obligations $22M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $22M
Other Current Liabilities $20M
Other Non Current Liabilities $205K
Total Shareholder Equity $337M
Treasury Stock -
Retained Earnings -$873M
Common Stock $68K
Common Stock Shares Outstanding $56M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$126M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.5M
Capital Expenditures $4.1M
Change In Receivables -
Change In Inventory $1.6M
Profit Loss -
Cashflow From Investment -$219M
Cashflow From Financing $164M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$131M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $40M
Total Revenue $43M
Cost Of Revenue $3.7M
Costof Goods And Services Sold $3.7M
Operating Income -$146M
Selling General And Administrative $52M
Research And Development $133M
Operating Expenses $185M
Investment Income Net -
Net Interest Income $15M
Interest Income $15M
Interest Expense $14K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.5M
Income Before Tax -$131M
Income Tax Expense $90K
Interest And Debt Expense -
Net Income From Continuing Operations -$131M
Comprehensive Income Net Of Tax -
Ebit -$131M
Ebitda -$129M
Net Income -$131M

EYPT Profile

Eyepoint Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

EyePoint Pharmaceuticals, Inc. is a pioneering biopharmaceutical company based in Watertown, Massachusetts, dedicated to developing innovative therapeutics for serious ocular diseases. Utilizing its proprietary micro-insert technology, the company specializes in sustained-release drug delivery systems designed to meet significant unmet medical needs in ophthalmology. With a robust pipeline targeting conditions such as retinal diseases, EyePoint is strategically poised for growth in major markets, including the United States, China, and the United Kingdom, establishing itself as a critical contributor in the advancing field of eye care.

CHR
-45.66%
$0.07
NVVE
-5.52%
$0.19
MTC
+409.86%
$1.55
ASST
+18.80%
$1.48
RIVN
+23.70%
$15.46
BYND
-4.31%
$1.33
LNAI
+45.09%
$1.21
VHAI
0.00%
$0.00
NVDA
-1.61%
$195.48
GPUS
+8.87%
$0.38
PLUG
-8.36%
$2.52
RUBI
-49.75%
$0.30
PFE
+1.29%
$24.61
SLDP
+51.55%
$8.51
YDKG
-5.55%
$0.05
ETHD
+20.91%
$5.26
SMX
+38.80%
$2.04
T
-0.36%
$24.44
TSLA
+3.71%
$460.75
SOFI
-4.11%
$29.37
PLTR
-1.60%
$187.67
DNN
-2.18%
$2.68
AXDX
-61.36%
$0.03
F
+2.85%
$13.15
PINS
-22.92%
$25.36
ACHR
+0.26%
$9.58
AAL
+6.08%
$13.42
BITF
+6.11%
$4.07
CIFR
+9.77%
$24.71
AMD
+3.26%
$258.22
WTO
-1.40%
$0.04
SMCI
-11.11%
$42.13
TEVA
+20.16%
$24.58
INTC
+3.96%
$38.50
BAC
-2.04%
$52.44
SNAP
-2.45%
$7.28
KVUE
+1.94%
$16.28
ADAP
-15.14%
$0.05
ONDS
-0.25%
$5.94
NFE
+13.99%
$1.53
AMCR
+3.04%
$8.11
BTG
+1.12%
$4.04
IREN
-1.65%
$66.63
RXRX
-8.08%
$5.00
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
RGTI
+5.99%
$37.29
MARA
+3.70%
$17.23
RMBL
+60.50%
$3.21
JOBY
-9.55%
$14.76
RIG
+0.38%
$3.91
ADD
-25.47%
$0.05
WBD
+0.53%
$22.71
BURU
-2.17%
$0.28
QS
+9.93%
$16.97
GRAB
-2.76%
$5.62
WULF
+2.46%
$15.38
CAN
+14.43%
$1.27
BTBT
+3.14%
$3.28
EPWK
-7.75%
$0.06
FUBO
+11.27%
$4.09
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
NVO
+1.01%
$48.73
ZDAI
+13.94%
$0.52
U
+17.45%
$42.13
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
APPS
+23.14%
$7.29
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
BMNR
+4.96%
$41.42
KDLY
-11.88%
$0.78
NGD
+2.48%
$6.80
NIO
+2.30%
$7.32
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
CGC
-5.83%
$1.12
RIOT
-2.90%
$18.71
HPE
+0.59%
$23.70
PCG
+1.05%
$16.32
AG
-7.82%
$10.65
ETWO
0.00%
$3.30
HOOD
-6.98%
$136.80
RDHL
+0.88%
$1.08
NCLH
-1.25%
$18.55
ITUB
+1.55%
$7.49
AMZN
-0.36%
$248.42
BW
+38.55%
$5.18
CMG
+0.96%
$32.04
QBTS
+4.90%
$31.19
GOOGL
+2.47%
$284.42
MSPR
-27.89%
$0.47
AAPL
-0.18%
$269.53
IONZ
-7.18%
$4.14
SOUN
+2.36%
$15.48
TREX
-31.07%
$32.42
PLTD
+1.97%
$6.47
PLTZ
+2.69%
$6.23
AFMD
-34.94%
$0.18
CHR
-45.66%
$0.07
NVVE
-5.52%
$0.19
MTC
+409.86%
$1.55
ASST
+18.80%
$1.48
RIVN
+23.70%
$15.46
BYND
-4.31%
$1.33
LNAI
+45.09%
$1.21
VHAI
0.00%
$0.00
NVDA
-1.61%
$195.48
GPUS
+8.87%
$0.38
PLUG
-8.36%
$2.52
RUBI
-49.75%
$0.30
PFE
+1.29%
$24.61
SLDP
+51.55%
$8.51
YDKG
-5.55%
$0.05
ETHD
+20.91%
$5.26
SMX
+38.80%
$2.04
T
-0.36%
$24.44
TSLA
+3.71%
$460.75
SOFI
-4.11%
$29.37
PLTR
-1.60%
$187.67
DNN
-2.18%
$2.68
AXDX
-61.36%
$0.03
F
+2.85%
$13.15
PINS
-22.92%
$25.36
ACHR
+0.26%
$9.58
AAL
+6.08%
$13.42
BITF
+6.11%
$4.07
CIFR
+9.77%
$24.71
AMD
+3.26%
$258.22
WTO
-1.40%
$0.04
SMCI
-11.11%
$42.13
TEVA
+20.16%
$24.58
INTC
+3.96%
$38.50
BAC
-2.04%
$52.44
SNAP
-2.45%
$7.28
KVUE
+1.94%
$16.28
ADAP
-15.14%
$0.05
ONDS
-0.25%
$5.94
NFE
+13.99%
$1.53
AMCR
+3.04%
$8.11
BTG
+1.12%
$4.04
IREN
-1.65%
$66.63
RXRX
-8.08%
$5.00
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
RGTI
+5.99%
$37.29
MARA
+3.70%
$17.23
RMBL
+60.50%
$3.21
JOBY
-9.55%
$14.76
RIG
+0.38%
$3.91
ADD
-25.47%
$0.05
WBD
+0.53%
$22.71
BURU
-2.17%
$0.28
QS
+9.93%
$16.97
GRAB
-2.76%
$5.62
WULF
+2.46%
$15.38
CAN
+14.43%
$1.27
BTBT
+3.14%
$3.28
EPWK
-7.75%
$0.06
FUBO
+11.27%
$4.09
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
NVO
+1.01%
$48.73
ZDAI
+13.94%
$0.52
U
+17.45%
$42.13
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
APPS
+23.14%
$7.29
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
BMNR
+4.96%
$41.42
KDLY
-11.88%
$0.78
NGD
+2.48%
$6.80
NIO
+2.30%
$7.32
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
CGC
-5.83%
$1.12
RIOT
-2.90%
$18.71
HPE
+0.59%
$23.70
PCG
+1.05%
$16.32
AG
-7.82%
$10.65
ETWO
0.00%
$3.30
HOOD
-6.98%
$136.80
RDHL
+0.88%
$1.08
NCLH
-1.25%
$18.55
ITUB
+1.55%
$7.49
AMZN
-0.36%
$248.42
BW
+38.55%
$5.18
CMG
+0.96%
$32.04
QBTS
+4.90%
$31.19
GOOGL
+2.47%
$284.42
MSPR
-27.89%
$0.47
AAPL
-0.18%
$269.53
IONZ
-7.18%
$4.14
SOUN
+2.36%
$15.48
TREX
-31.07%
$32.42
PLTD
+1.97%
$6.47
PLTZ
+2.69%
$6.23
AFMD
-34.94%
$0.18
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.